Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/23/2010EP1735313B1 Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
06/23/2010EP1699782B1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
06/23/2010EP1670514B1 Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor
06/23/2010EP1646629B1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
06/23/2010EP1608400B1 Elevation of adenosine level by cytokine-induced expression of cd73
06/23/2010EP1594859B1 Indazolamides with analgesic activity
06/23/2010EP1511735B1 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors
06/23/2010EP1511734B1 Compounds, compositions, and methods
06/23/2010EP1363609B1 Anti-atherosclerosis composition comprising phytoene or phytofluene
06/23/2010CN201510537U Rosuvastatin acid double-release capsule
06/23/2010CN1993130B Processes and intermediates used for preparing fused heterocyclic kinase inhibitors
06/23/2010CN1934109B Composition for solid pharmaceutical preparation of solifenacin or salt thereof
06/23/2010CN1930123B Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
06/23/2010CN1926133B Epothilone derivatives
06/23/2010CN1926113B Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
06/23/2010CN1923285B Injectable sterile pharmaceutical formulation containing at least two active principles
06/23/2010CN1918157B Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
06/23/2010CN1909907B Quinoline derivatives and use thereof for preparing mycobacterial inhibitors
06/23/2010CN1906173B Protein modifier production inhibitor
06/23/2010CN1906155B Novel hydroxamic acid ester derivant and pharmaceutical use thereof
06/23/2010CN1903246B Medicine for setting broken bone
06/23/2010CN1902213B Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
06/23/2010CN1883566B Anti-inflammation medicine and method for preparing same
06/23/2010CN1879670B Toxin-extracting pain-easing ointment
06/23/2010CN1875004B Resolution of a narwedine amide derivative
06/23/2010CN1870980B Controlled release sterile injectable aripiprazole formulation and method
06/23/2010CN1870974B Method for producing injectable gabapentin compositions
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN1829503B Veterinary aqueous injectable suspensions containing florfenicol
06/23/2010CN1824056B Applicaiton of a Chinese-western medicine combined composition for preparing medicine and food dual purpose nutritive product for preventing and treating cataract
06/23/2010CN1824050B Applicaiton of a composition for preparing medicine and food dual purpose nutritive product for preventing and treating xeroma
06/23/2010CN1824042B Applicaiton of a composition for preparing medicine and food dual purpose nutritive product for preventing and treating computer vision syndrome
06/23/2010CN1824025B Applicaiton of a Chinese-western medicine combined composition for preparing medicine and frod dual purpose nutrient for preventing frue myopia
06/23/2010CN1821236B Therapeutic heterocyclic compounds
06/23/2010CN1809339B Oil emulsion for postnatal hormone substitution
06/23/2010CN1796400B Extractive of phytosterol extracted from bamboo shoot, preparation method and application
06/23/2010CN1777443B Methods of diagnosing and treating pre-eclampsia or eclampsia
06/23/2010CN1759834B Application of berberine or associated with Simvastatin in preparing product for preventing or curing disease or symptom related to blood fat
06/23/2010CN1697648B Azithromycin dosage forms with reduced side effects
06/23/2010CN1688194B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2010CN1679522B External dermatological agent
06/23/2010CN1620304B Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
06/23/2010CN1589166B Stent coated with a sustained-release drug delivery system and method for use thereof
06/23/2010CN101755049A A primary micro RNA expression cassette
06/23/2010CN101754974A Macrocyclic compounds as antiviral agents
06/23/2010CN101754972A Crystal structures of SGLT2 inhibitors and processes for preparing same
06/23/2010CN101754970A Macrocyclic indole derivatives for the treatment of hepatitis c infections
06/23/2010CN101754968A Substituted imidazopyridazines as PI3K lipid kinase inhibitors
06/23/2010CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors
06/23/2010CN101754966A Hepatitis c virus inhibitors
06/23/2010CN101754965A CSF-1R inhibitors, compositions, and methods of use
06/23/2010CN101754964A dna pk inhibitors
06/23/2010CN101754963A spirocyclopropyl piperidine derivatives
06/23/2010CN101754961A Pyrimidinone derivatives and methods of use thereof
06/23/2010CN101754960A Tetrahydropyranochromene gamma secretase inhibitors
06/23/2010CN101754958A Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone
06/23/2010CN101754957A Novel heterocyclyl compounds and their use as chemokine antagonists
06/23/2010CN101754956A Substituted indazole derivatives active as kinase inhibitors
06/23/2010CN101754955A Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases
06/23/2010CN101754954A Nitrogen-containing heterocyclic derivative having 11 ss-hydroxysteroid dehydrogenase type I inhibitory activity
06/23/2010CN101754953A Salts of perindopril
06/23/2010CN101754774A Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
06/23/2010CN101754765A emulsion compositions
06/23/2010CN101754764A Compositions and method for treating pediatric hypogonadism
06/23/2010CN101754763A Metal complexes incorporated within biodegradable nanoparticles and their use
06/23/2010CN101754762A Formulations containing pyrid azine compound field of invention
06/23/2010CN101754761A compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
06/23/2010CN101754760A Pharmaceutical composition for amelioration of lower urinary tract symptom associated with prostatomegaly
06/23/2010CN101754759A Quinoline derivatives as PI3 kinase inhibitors
06/23/2010CN101754758A A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
06/23/2010CN101754757A Medicated patch comprising 5-methyl-1-phenyl-2-(1h)-pyridone
06/23/2010CN101754756A Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment
06/23/2010CN101754754A Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof
06/23/2010CN101754753A Sustained release formulation of melatonin
06/23/2010CN101754752A Extended release formulations comprising quetipine and methods for their manufacture
06/23/2010CN101754750A Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process
06/23/2010CN101754749A An inhalable medicament
06/23/2010CN101754748A Formulations and methods for treating dry eye
06/23/2010CN101754747A Methods and compositions for delivery of medicaments to the lungs
06/23/2010CN101754746A Dry-powder medicament
06/23/2010CN101754694A Supporting activities of daily living
06/23/2010CN101754687A Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
06/23/2010CN101754681A therapeutic pyrazolonaphthyridine derivatives
06/23/2010CN101754678A Short acting phenylalkylamine calcium channel blockers and uses thereof
06/23/2010CN101748125A siRNA segment and application thereof used for curing and/or preventing Porcine Reproductive and Respiratory Syndrome
06/23/2010CN101748124A siRNA segment and application thereof used for curing and/or preventing Peste des petits ruminants
06/23/2010CN101748120A Interference RNA interfering muscle specific E3 ubiquitin protein ligase gene, carrier containing same and application thereof
06/23/2010CN101747446A Method for extracting anti-fatigue acidic ginseng polysaccharide
06/23/2010CN101747405A Berberine glycyrrhizic acid enantiomer salt and preparation method and usage thereof
06/23/2010CN101747404A Glycyrrhetinic acid cyclic phosphonate ester derivative and preparation method thereof
06/23/2010CN101747400A Lanostane type triterpenoid with anti-tumor activity, preparation method and application
06/23/2010CN101747384A 5-chlorine salicylyl hydrazine triphenyltin chloride coordination compound, as well as preparation method and application thereof
06/23/2010CN101747382A Ruthenium polypyridyl complex using quinolones compound as ligand, preparation method and application thereof
06/23/2010CN101747354A Dipeptide boronic acids consisting of beta amino acids, ester compounds and preparation methods and uses thereof
06/23/2010CN101747353A N'-(3-nitrobenzoyl)-N-salicylyl hydrazne copper complex as well as preparation method and application thereof
06/23/2010CN101747345A Amorphous cefodizime sodium and preparation method thereof and pharmaceutical composition comprising same
06/23/2010CN101747339A 1'-thio-aza indirubin compound, application and preparation method thereof
06/23/2010CN101747331A Isoniazid thiadiazine thione derivative
06/23/2010CN101747330A Pyridyl thiazole amines compound, as well as medical composite and application thereof
06/23/2010CN101747329A 4-arylthioquinazoline derivatives and preparation methods and pharmaceutical uses thereof
1 ... 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 ... 7860